Related Experiment Video
Updated: Sep 23, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA
Xiaojin Song1, Bing Chen2, Yiran Liang1
1Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong Province, 250012, China.
Abstract:
Triple-negative breast cancer (TNBC) is a molecular subtype with an unfavorable prognosis, and metastasis is the main reason for the failure of clinical treatment. However, the expression profile and regulatory function of circRNAs in TNBC progression are not fully understood. Herein, we performed high-throughput RNA-seq in paired breast cancer tissues and adjacent normal tissues and discovered a novel circRNA, circEIF3H, which was upregulated in breast cancer tissues. Large cohort survival analysis confirmed the association between high circEIF3H expression and poor prognosis of TNBC, indicating the vital function of circEIF3H in TNBC progression. Then we conducted both in vitro and in vivo experiments which illustrated that circEIF3H was essential for TNBC proliferation and metastasis. Further experiments showed that circEIF3H did not function as a microRNA sponge as in the most well-established pathway, but as a scaffold for IGF2BP2 and HuR to regulate the mRNA stability of HSPD1, RBM8A, and G3BP1. Our findings provide insight into a novel circRNA, circEIF3H, with significant cancer-promoting function via serving as a scaffold for IGF2BP2/HuR. These results identified circEIF3H as a potential target for developing individualized therapy of TNBC in the approaching future.
Insights
A novel circular RNA, circEIF3H, promotes triple-negative breast cancer (TNBC) progression and metastasis. It acts as a scaffold protein, offering a potential new therapeutic target for TNBC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) presents a poor prognosis, with metastasis being a primary cause of treatment failure.
- The role of circular RNAs (circRNAs) in TNBC progression remains incompletely understood.
- Identifying novel molecular mechanisms driving TNBC is crucial for developing effective therapies.
Purpose of the Study:
- To identify and characterize novel circRNAs involved in triple-negative breast cancer (TNBC) progression.
- To elucidate the functional role and regulatory mechanism of the identified circRNA in TNBC.
- To evaluate the potential of the novel circRNA as a therapeutic target for TNBC.
Main Methods:
- High-throughput RNA sequencing of paired breast cancer and adjacent normal tissues.
- In vitro and in vivo experimental models to assess TNBC proliferation and metastasis.
- Biochemical assays to investigate the molecular mechanism of circRNA function.
Main Results:
- A novel circRNA, circEIF3H, was discovered and found to be upregulated in breast cancer tissues.
- High circEIF3H expression correlated with poor prognosis in TNBC patients.
- circEIF3H was essential for TNBC proliferation and metastasis, functioning as a scaffold for IGF2BP2 and HuR to stabilize specific mRNAs.
Conclusions:
- circEIF3H is a novel, cancer-promoting circRNA significantly upregulated in TNBC.
- circEIF3H drives TNBC progression and metastasis by scaffolding IGF2BP2/HuR, independent of microRNA sponging.
- circEIF3H represents a promising novel therapeutic target for individualized TNBC treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Negative Regulator Molecules
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...